Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Transfusion01:15

Blood Transfusion

860
Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
860
Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

11.4K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
11.4K
Hematopoiesis01:21

Hematopoiesis

5.8K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.8K
Erythropoiesis01:14

Erythropoiesis

4.9K
Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia,...
4.9K
Overview of Hematopoiesis01:20

Overview of Hematopoiesis

5.3K
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
5.3K
Rh Blood Group01:19

Rh Blood Group

2.0K
The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
2.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnostic performance and interchangeability of two commercial anti-RSV-IgG and IgA ELISAs across clinically relevant populations.

Microbiology spectrum·2026
Same author

Anemia and Iron Deficiency in Cardiac Surgery Patients: Prevalence, Implications, and Therapeutic Considerations.

Journal of clinical medicine·2025
Same author

Correction: Niederhauser et al. Anti-SARS-CoV-2 Antibody Development over Four Years in Blood Donors. <i>Viruses</i> 2025, <i>17</i>, 1292.

Viruses·2025
Same author

Anti-SARS-CoV-2 Antibody Development over Four Years in Blood Donors.

Viruses·2025
Same author

Surveillance of blood donors detects an exceptional Parvovirus B19 outbreak in Switzerland in 2023/2024.

Blood transfusion = Trasfusione del sangue·2025
Same author

Clinical implications of sex-specific upper reference limits for high-sensitivity cardiac troponin I in myocardial infarction diagnosis.

Revista espanola de cardiologia (English ed.)·2025

Related Experiment Video

Updated: Oct 5, 2025

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
07:24

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

1.8K

The EHA Research Roadmap: Transfusion Medicine.

Simon J Stanworth1,2,3, Anneke Brand4, Srini V Kaveri5

  • 1Transfusion Medicine, NHS Blood and Transplant, Oxford, United Kingdom.

Hemasphere
|January 31, 2022
PubMed
Summary

The European Hematology Association (EHA) updated its research roadmap to address urgent needs in hematology. This roadmap guides future research and policy for blood disorder diagnostics and treatment.

More Related Videos

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
11:59

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

7.5K
Author Spotlight: Advancing Erythropoiesis Research - A Simplified Pipeline for Assessing Hematopoietic Stem Cell Function in Myelodysplastic Syndromes
08:53

Author Spotlight: Advancing Erythropoiesis Research - A Simplified Pipeline for Assessing Hematopoietic Stem Cell Function in Myelodysplastic Syndromes

Published on: January 10, 2025

628

Related Experiment Videos

Last Updated: Oct 5, 2025

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
07:24

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

1.8K
Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
11:59

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

7.5K
Author Spotlight: Advancing Erythropoiesis Research - A Simplified Pipeline for Assessing Hematopoietic Stem Cell Function in Myelodysplastic Syndromes
08:53

Author Spotlight: Advancing Erythropoiesis Research - A Simplified Pipeline for Assessing Hematopoietic Stem Cell Function in Myelodysplastic Syndromes

Published on: January 10, 2025

628

Area of Science:

  • Hematology
  • Translational Research
  • Medical Science

Background:

  • The European Hematology Association (EHA) initially published a roadmap in 2016 to identify key priorities in European hematology research.
  • Significant advancements in hematology necessitate an updated roadmap to reflect current scientific and clinical needs.
  • The roadmap aims to inform policymakers and stakeholders about critical areas requiring attention and funding.

Discussion:

  • The updated EHA Research Roadmap encompasses eleven distinct sections, each addressing specific subfields within hematology.
  • Each section is curated by leading international experts to ensure comprehensive and accurate identification of research priorities.
  • The roadmap highlights urgent clinical and scientific needs across the spectrum of blood disorders.

Key Insights:

  • The updated roadmap identifies critical priorities for hematology research and clinical science.
  • It serves as a guide for a more informed, focused, and potentially better-funded future for European hematology.
  • The document covers a broad range of hematological topics, from normal hematopoiesis to advanced therapies like CAR-T and gene therapy.

Outlook:

  • This updated roadmap is expected to foster more strategic research investments and collaborations within European hematology.
  • It provides a framework for addressing unmet needs in the diagnosis and treatment of blood disorders.
  • The EHA aims to facilitate progress in the field, ultimately improving patient outcomes for blood-related diseases.